Medical Affairs Reputations (EU5): Type 2 Diabetes Mellitus
|歐盟5國的醫療事務的評估:第二型糖尿病 (T2DM) Medical Affairs Reputations (EU5): Type 2 Diabetes Mellitus|
|出版日期: 2015年09月01日||內容資訊: 英文 PowerPoint||
本報告提供第二型糖尿病 (T2DM) 治療藥的主要10項產品相關的醫療事務 (MA) 隊伍以歐洲的150名醫生為對象的調查，最重要的MA提供內容，最受尊重的MA團隊和其他團隊的差異，對MA提供內容的滿意度，愛好的傳達手段，改善的機會等相關彙整。
What do physicians think of Europe Medical Affairs teams in the Type 2 Diabetes Mellitus (T2DM) sector? Who gets top marks for performance and reputation? Who fails to measure up? How is your Medical Affairs team impacting your relationship with customers?
To find out, we surveyed 150 physicians from across the continent regarding ten leading T2DM products and their associated Medical Affairs teams.
What did they have to say about your team? Are you lagging or leading your competitors? Order your report now to find out.
Note that in addition to the Europe report we offer an equivalent report for the U.S. Order both and receive, at no cost, a third report clearly setting out the differences in findings between the two regions.
Medical Affairs teams in T2DM are generally well received, but physicians do have several recommendations for improvement; we provide the details.
Some Medical Affairs offerings are highly desired by physicians. Others generate much less interest. We let you know where your team might make adjustments and strengthen relationships as a result.
The products leading in the marketplace don't necessarily lead in Medical Affairs. Which teams are doing their T2DM products justice? Which might be dragging them down?
This report lets you know.